Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
3
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
biotech
crispr
crispr therapeutics
deals
national
sherlock biosciences
startups
abbvie
adverum biotechnologies
albert bourla
alphabet
alzheimer's disease
amgen
amicus therapeutics
arvinas
batten disease
bayer
biogen
boulder/denver blog main
boulder/denver top stories
breast cancer
brian stuglik
broad institute of harvard and mit
brook byers
cancer
cancer diagnostics
cancer immunotherapy
casimir trials
celenex
charles chu
christine mcsherry
chuck schumer
clinial trials
What
crispr
3
×
today
3
×
bio
cas
acquisitions
albert
available
based
big
biggest
biosciences
bourla
cancer
cells
ceo
cheaper
company
defect
develop
diagnostics
drive
drug
edited
editing
expects
faster
fears
flag
future
gene
genetic
guardian
human
imports
known
lab
maker
malfunction
mammoth
maps
Language
unknown
unset
Current search:
crispr
×
today
×
" boston top stories "
×
@xconomy.com
4 years ago
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells